- Home
- WKHS vs INKT Comparison
WKHS vs INKT Comparison
Compare WKHS & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKHS | INKT |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 57.6M |
| IPO Year | 2008 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WKHS | INKT |
|---|---|---|
| Price | $3.20 | $8.88 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $21.00 | ★ $35.00 |
| AVG Volume (30 Days) | 61.8K | ★ 157.7K |
| Earning Date | 04-01-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $763,173.00 | N/A |
| Revenue This Year | $81.01 | N/A |
| Revenue Next Year | $34.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $6.66 |
| 52 Week High | $11.80 | $76.00 |
Technical Indicators
Market Signals| Indicator | WKHS | INKT |
|---|---|---|
| Relative Strength Index (RSI) | 35.12 | 36.60 |
| Support Level | $0.92 | $6.80 |
| Resistance Level | $3.60 | $12.64 |
| Average True Range (ATR) | 0.19 | 0.80 |
| MACD | 0.02 | -0.17 |
| Stochastic Oscillator | 21.05 | 2.44 |
Price Performance
Historical ComparisonAbout WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.